
|Slideshows|November 22, 2016
AHA 2016: Cardiovascular Health and Cognition
Author(s)Samantha J. Peterson
Do lipid-lowering medications or low vitamin D levels in mid-life cause neurocognitive deficits? What effect does hypotension have on TBI outcomes?
Advertisement
Presentations at the American Heart Association Scientific Sessions examined the association of PCSK9 inhibitors and neurocognitive deficits, the effect of depth and dose of hypotension on mortality in traumatic brain injury, and a possible link between low vitamin D levels in mid-life and cognitive deficits 20 years later.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Newly Unveiled EPIC Trial Pins Myasthenia Gravis Medications Nipocalimab Against Efgartigimod for Efficacy
2
Phase 3 MG0020 Trial Highlights Success of Self-Administered Rozanolixizumab for Generalized Myasthenia Gravis
3
B-Cell Modulator Obexelimab Shows Pronounced Relapse Reduction in Phase 2 MoonStone Trial
4
Efgartigimod Treatment for CIDP Leads to Increased Spending, Study Shows
5






































